Kentucky recalls
3523 federal recalls on file affecting Kentucky - 449 Kentucky-specific plus 3074 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-03-11FDA-DrugStuffby NainaxClass INationwideStop using MR. 7 SUPER 700000 capsules
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
- 2026-03-11FDA-DrugMohamed HagarClass INationwideStop using Mojo Max Fusion XXX capsules
Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
- 2026-03-11FDA-DrugRadnostixClass IINationwideDo not use Radnostix Sodium Iodide I-131 solution
Presence of Particulate Matter: Due to production issues
- 2026-03-11FDA-Drug123HerbalsClass INationwideStop using SILINTAN 25 pills immediately
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
- 2026-03-11FDA-DrugKirkmanClass IINationwideStop using Kirkman Maximum Zone 2 lidocaine cream
Stability Data Does Not Support Expiry Date.
- 2026-03-11FDA-DrugKirkmanClass IINationwideStop using Kirkman Maximum Zone 1 Lidocaine Cream
Stability Data Does Not Support Expiry Date.
- 2026-03-11FDA-DrugKirkmanClass IINationwideStop using Kirkman VASOCAINE Spray
Stability Data Does Not Support Expiry Date.
- 2026-03-11FDA-DrugRising PharmaClass IINationwideStop using Rising Pharma Temozolomide capsules
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
- 2026-03-11FDA-DrugThe Harvard DrugClass IINationwideCheck midodrine hydrochloride tablets for damaged packaging
Defective container; inadequately sealed blister packaging.
- 2026-03-11FDA-DrugCiplaClass IIINationwideStop using Cipla Nilotinib capsules, Lot 5GJ0223
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
- 2026-03-11FDA-DrugCiplaClass IIINationwideStop using Cipla Nilotinib 150 mg capsules
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
- 2026-03-11FDA-DrugHarbin Jixianglong BiotechClass IINationwideContact your pharmacy about semaglutide
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
- 2026-03-11FDA-DrugJixianglongClass IINationwideDo not use Harbin Jixianglong semaglutide
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
- 2026-03-11FDA-DrugAcme UnitedClass IINationwideStop using ACME United hand wipes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Children's Healthcare hand sanitizer wipes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Dynarex BZK Antiseptic Towelettes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Dynarex BZK Antiseptic Towelettes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Green Guard Antiseptic Wipes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Acme United hand sanitizing wipes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using WP WipesPlus Hand Sanitizing Wipes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Acme United Med-Nap Cleansing Towelettes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using ACME Med-Nap cleansing towelettes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Dynarex Obstetrical Towelettes Cleanser
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Wipes Plus hand sanitizing wipes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using ACME BZK Antiseptic Towelettes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Med Nap BZK Antiseptic Towelettes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Medi-First Antiseptic Wipes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Savannah Antibacterial Towelettes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using Max Packaging antibacterial towelettes
CGMP Deviations
- 2026-03-11FDA-DrugAcmeClass IINationwideStop using recalled BZK Antiseptic Towelettes
CGMP Deviations
Get notified about new Kentucky recalls
Free weekly digest. Add Kentucky to your profile to filter alerts to your state.
Get the Sunday Brief